SpringWorks Therapeutics, Inc.
Learn how SpringWorks Therapeutics Investor Relations leverages Irwin to support essential IR workflows.
Independence Contract Drilling is a premium land drilling services provider. From their corporate headquarters in Houston, Texas, they develop and assemble ShaleDriller® series rig designs based on E&P operator feedback and field requirements. ShaleDriller series rigs are AC programmable, energy-efficient Dual-Fuel, and custom designed to be best in class for developing their clients' most demanding and financially impactful exploration and development programs.
Save this case study for later:
Independence Contract Drilling's (ICD) vision is to be the leader in Health, Safety & Environment and Operational Excellence while providing services to support North American energy development. They aim to deliver the industry's safest and most efficient contract drilling services while reducing their carbon footprint.
When Philip Choyce, Executive Vice President, Chief Financial Officer & General Counsel, founded ICD, he couldn't have predicted the plunge that oil prices took in 2020 due to the COVID pandemic. Various factors forced pressure on petroleum prices, leading to the most dramatic drop in price ever recorded. Petroleum prices reached negative levels in May 2020, and the U.S. land rig count—a key barometer for ICD's business—fell to record lows, shattering previous land rig lows.
This downturn in the oil and natural gas industry caused Choyce and ICD to lose the interest of several key analysts and, subsequently, important institutional research coverage. ICD’s institutional shareholder support, which had been strong prior to the pandemic, also was materially negatively impacted. That's why Choyce knew he needed to reevaluate the company's investor relations strategy when the oil and natural gas industry began to grow again. He needed to reinvigorate ICD's analyst coverage and get the word out about the business while reestablishing and rebuilding ICD's shareholder base. That's where Irwin's Capital Markets Strategy Services—specifically the Analyst Targeting solution—come into play.
"I wanted to improve the effectiveness and productivity of our investor outreach efforts while growing the number of analysts covering the ICD stock. Irwin has helped me to be incredibly deliberate in tracking whether or not our efforts have been successful in investor outreach and analyst coverage efforts."
Choyce chose to move forward with Irwin's Capital Markets Strategy Services because it gave him a new avenue to uncover relevant analysts that are well-suited to cover ICD’s evolving story.
Here are three reasons he loves using Irwin:
With Irwin, Choyce now better understands relevant analysts within the energy and oil industry. He can easily distinguish between analysts based on the criteria most important to him.
"Once we implemented Irwin, the first thing we had to do was to reinvigorate our analyst coverage. They provided an in-depth list of who was legitimate and could help grow visibility for the ICD stock. It's been very successful, and I’ve been very pleased with what Irwin has done for me in that capacity."
Irwin's Analyst Targeting service also saves Choyce significant time searching for the right analysts to cover ICD—allowing him to focus on other tasks while being able to remain an IR team of one.
“ICD is not a large enough company to logically hire a full-time investor relations associate to do the things Irwin does. From a cost-efficiency perspective, Irwin has been a game-changer."
Choyce wanted a tool that improved the effectiveness and productivity of his investor outreach efforts while still allowing him to increase investor engagement and ownership. This is where Irwin's Enhanced Investor Targeting comes into play.
“For myself and ICD, tracking our shareholders has gotten more important because we had to adjust who our stockholder base was while repositioning ICD in the marketplace. Irwin’s targeting capabilities have been very effective because there is less of the unknown from an investor perspective.”
Irwin's Board Reporting offering allows Choyce to organize critical information in a comprehensive board report customized to ICD's needs. This report saves Choyce time on monthly/quarterly reporting while having increased insight into ICD's shareholder base, relative positioning vs. peers, and consensus views.
“Irwin has been very helpful in putting key information together that is not only professional and incredibly useful—but [presents it] in a way our board wants to see. The information included in the reports, including how the business is doing overall and how we're targeting stockholders, have all had a significant impact on the success of ICD.”
Choyce and ICD began to use Irwin in July 2021. Since then, Irwin’s investor relations software and services have unlocked and enhanced investor and shareholder relationships for the business, helping ICD achieve the following results:
“Irwin provides ICD with a systematic approach to communicating with current and future investors while measuring and tracking stock performance. Plus, the platform has helped me focus my time on analysts that could make a difference to the share price, which makes a significant impact in the long run.”
Philip Choyce
Executive Vice President, Chief Financial Officer & General Counsel
Learn how Irwin can help you improve your analyst coverage.
Learn how SpringWorks Therapeutics Investor Relations leverages Irwin to support essential IR workflows.
Learn why Vista Gold switched to Irwin, and how the team is leveraging Irwin’s outreach capabilities and support to generate success.
Learn why the Delta IR team switched to Irwin and how they use it to drive efficiency and value.